Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shionogi To Invest In New Research Facility And Consolidate Kansai Bases

This article was originally published in PharmAsia News

Executive Summary

Shionogi announced Jan. 28 plans to invest ¥14 billion toward building a new research facility in Fuchu, Osaka. Shionogi will consolidate its three research facilities currently spread throughout the Kansai area - Osaka City, Setsu City and Kouka City - and move around 700 researchers into the new facility, in which drug development and safety research will be conducted. The new facility is scheduled to begin operation in summer 2010. Takeda, another Osaka-based pharmaceutical giant, has set up a new research institute in Kanagawa prefecture. (Click here for more-Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel